IPL Optilight Therapy

IPL (Intense Pulsed Light) Optilight by Lumenis is the first and only FDA-approved IPL device specifically indicated for dry eye disease due to meibomian gland dysfunction (MGD). It represents a significant advancement in dry eye care — addressing the root cause rather than just managing symptoms.

During an IPL session, precisely calibrated pulses of light are applied to the skin around the eyes. This light energy targets abnormal blood vessels that contribute to eyelid inflammation, reduces Demodex mite populations, and stimulates the meibomian glands to produce healthier, more fluid oil. The result is improved tear film stability and lasting dry eye relief.

Most patients undergo a series of 4 treatments spaced 2–4 weeks apart, followed by maintenance sessions as needed. IPL is safe, non-invasive, and typically takes about 15 minutes per session. Many patients notice improvement after just 1–2 treatments, with optimal results after completing the full series.